baber/WOPTO huggingface dataset:
Patent AU-4242701-A (AU)
Title: Method for producing a surface-alloyed cylindrical, partially cylindrical or hollow cylindrical component and a device for carrying out said method
Inventor: FISCHER ALEXANDER
IPC: B23K26/34
Filed: 2001-02-21
Abstract: The invention relates to a method for manufacturing a surface-alloyed cylindrical, partly cylindrical or hollow cylindrical structural member where in the zone of incidence of the energy beam there is formed a locally bounded melting bath with a heating and melting front, a solution zone and a solidification front. At the side of the energy beam the hard material powder is deposited via a conveyor device in the direction of gravity and is supplied co-ordinated with the feed movement of the workpiece in a width which corresponds to the width of the linear focus and a layer height of 0.3-3 mm is thereby produced. The hard-material powder supplied to the workpiece surface in the heating front of the melting bath is heated by an energy beam at a wavelength of 780-940 nm and in contact with the liquefied matrix alloy the powder is immediately dissolved in the melting bath. Convection is produced in the solution zone by the energy beam having a specific power of at least 10<4 >W/cm<2>, so that the homogenization process in the melting zone is accelerated, where the linear focus acts on the solution zone until the hard material powder is uniformly distributed in the melting bath. In front of the energy beam the uniformly distributed powder material, which has gone into solution metallurgically in the solution zone, is subjected to directional solidification in the solidification front at a high cooling rate of 200-600 K/s at a feed rate of 500-10,000 mm/min. The invention also relates to a device for implementing the method, consisting of a workpiece clamping device, on which a workpiece is aligned and clamped above index holes and/or above working surfaces, onto whose surface a powder supply and a focusable beam from a beam head are directed.
Patent AU-4537385-A (AU)
Title: Double sulfate of desoxyfructosyl serotonin and creatinine
Inventor: BERTHOLET RAYMOND
IPC: C07D233/88
Filed: 1985-07-25
Abstract: A double sulfate salt of 1-desoxy-(5-hydroxytryptamino)-D-fructose (DSF) and 1-methylhydantoin-2-imide (creatinine) represents a new solid crystalline phase of unit composition, pharmaceutical quality and remarkable stability. It is prepared by glycosylation of serotonin with D-glucose, formation of the double salt by addition of sulfuric acid and creatinine and crystallization of the double salt in the presence of ethanol. The DFS is preferably isolated from the reaction medium by way of the addition complex DFS.Ca(OH)2 which is precipitated by the addition of calcium hydroxide. The calcium hydroxide is then eliminated by addition of sulfuric acid and the double salt is crystallized as described above. DFS is the active principle of a medicament effective, in particular, in the treatment of leprosy.
Patent AU-4730500-A (AU)
Title: Identity-coded surface
Inventor: SILVERBROOK KIA
IPC: G06F17/30
Filed: 2000-05-24
Abstract: A system is provided having a sensing device for sensing data encoded by a plurality of marks at predetermined positions within a region. The data encoded by each mark is indicative of a functional attribute of that mark's predetermined position. The sensing device is configured to transmit, to a computer system, the sensed data such that the computer system causes execution of a function related to the functional attribute of the sensed data.
Patent AU-4838801-A (AU)
Title: Methof of determining speed of rotation of a motor and a computer software product to carry out the method
Inventor: SAARINEN KARI
IPC: G01P3/44
Filed: 2001-03-19
Abstract: The present invention relates to a method of determining speed of rotation of a motor. The method involves collecting samples with a measuring sensor at a sampling frequency, set on the basis of mechanical vibration of the motor, for the duration of a measurement period and storing the samples in the memory of a data carrier as measurement data of a fixed format. The speed of rotation of the motor is determined from the measurement data by determining the cycle length of a periodic vibration signal in the time domain by means of a maximum likelihood estimate calculated by maximizing a maximum likelihood function adjusted to the measurement data, the speed of rotation being obtained from the frequency point where the maximum likelihood function obtains its maximum value.
Patent AU-4952596-A (AU)
Title: A therapeutic bed
Inventor: CONNOLLY PATRICK JOSEPH
IPC: A61G7/008
Filed: 1996-02-26
Abstract: PCT No. PCT/IE96/00009 Sec. 371 Date Sep. 8, 1997 Sec. 102(e) Date Sep. 8, 1997 PCT Filed Feb. 26, 1996 PCT Pub. No. WO96/27356 PCT Pub. Date Sep. 12, 1996A therapeutic hospital bed (1) comprises a patient support platform (2) rotatably and pivotally secured within a main bed frame (3). The main bed frame (3) is supported on a base frame (5). An end board on the patient support platform (2) has an arcuate track (14) engaged by a drive belt (15) which is connected to a drive motor for oscillating the patient support platform (2) relative to the main bed frame (3). Opposite ends of the drive belt (15) are connected to disengagement arms (18, 25) which are pivotally interconnected to form a scissors mechanism. The arms (18, 25) are operable to tension or release the belt (15) to engage or disengage drive to the patient support platform (2). A spring (27) extends between the arms (18, 25) to bias the arms (18, 25) into a belt tensioning position. To disengage the drive for turning the patient support platform (2) manually, the arms (18, 25) are movable against spring bias to a disengaged position. When the arms (18, 25) are subsequently released the spring (27) returns the arms (18, 25) to the belt tensioning position to engage the drive.
Patent AU-4987501-A (AU)
Title: Safety device for use with a vial
Inventor: MACLEAN DAVID
IPC: A61M5/24
Filed: 2001-04-05
Abstract: A safety device to be used with a vial, or capsule, has a collar dimensioned to slidably fit about the body of the vial. Extending from the collar is a neck member that has connected to its other end a housing pivotable to a position along the longitudinal axis of the vial. A latch member having a lip is integrated to the neck member and extends out from the neck member in a direction towards the center of the collar. Neck member is fabricated to have an elastic characteristic so that if it is not biased by any external force, it will return to its original position. As the collar of the safety device is moved along the body of the vial, neck member is biased away from the vial as the latch member maintains contact along the outer surface of the vial, and then the outer surface of the hub formed at the top end of the vial. Once the collar of the safety device is moved to a position adjacent the hub, given the configuration of the neck member forms a space between the top of the collar and the lip of the latch member, the hub of the vial would fit within the space thus formed, as neck member snaps back to its original position. At which time the lip of latch member latches onto a shoulder portion of the hub. Once latched onto the hub, the latch member would prevent the safety device from being removed from the vial. Instead of the neck member, another embodiment of the inventive safety device has extending from the collar a rigid support frame and an elongate elastic latch member.
Patent AU-5027600-A (AU)
Title: Method for sequencing nucleic acid molecules
Inventor: KORLACH JONAS
IPC: C12Q1/6874
Filed: 2000-05-18
Abstract: The present invention is directed to a method of sequencing a target nucleic acid molecule having a plurality of bases. In its principle, the temporal order of base additions during the polymerization reaction is measured on a molecule of nucleic acid, i.e., the activity of a nucleic acid polymerizing enzyme on the templage nucleic acid molecule to be sequenced is followed in real-time. The sequence is deduced by identifying which base is being incorporated into the growing complementary strand of the target nucleic acid by the catalytic activity of the nucleic acid polymerizing enzyme at each step in the sequence of base additions. A polymerase on the target nucleic acid molecule complex is provided in a position suitable to move along the target nucleic acid molecule and extend the oligonucleotide primer at an active site. A plurality of labelled types of nucleotide analogs are provided proximate to the active site, with each distinguishable type of nucleotide analog being complementary to a different nucleotide in the target nucleic acid sequence. The growing nucleic acid strand is extended by using the polymerase to add a nucleotide analog to the nucleic acid strand at the active site, where the nucleotide analog being added is complementary to the nucleotide of the target nucleic acid at the active site. The nucleotide analog added to the oligonucleotide primer as a result of the polymerizing step is identified. The steps of providing labelled nucleotide analogs, polymerizing the growing nucleic acid strand, and identifying the added nucleotide analog are repeated so that the nucleic acid strand is further extended and the sequence of the target nucleic acid is determined.
Patent AU-5106485-A (AU)
Title: Immuno reactive porous carrier material
Inventor: SCHAFER RAINER
IPC: G01N33/543
Filed: 1985-12-10
Abstract: The present invention provides a process for the preparation of an immuno-reactive, porous carrier material by application of a solution of a first reaction component of an immuno-reaction and of a solution of a second component of an immuno-reaction coprecipitating therewith, incubation of the carrier material impregnated with the solutions for the immuno-precipitation, optional washing and subsequent drying of the impregnated carrier material, wherein a solution of both components of the immuno-reaction is prepared, which solution contains an inhibitor for the immuno-precipitation, the carrier material is impregnated with this solution and then the immuno-precipitation is initiated by removal of the inhibitor or by removal of the inhibiting action.
Patent AU-5222201-A (AU)
Title: Pharmaceutically active pyrrolidine derivatives as bax inhibitors
Inventor: HALAZY SERGE
IPC: A61K31/4184
Filed: 2001-03-20
Abstract: The present invention is related to new substituted pyrrolidine derivatives of formula (I). Said compounds are preferably for use as pharmaceutically active compounds. Specifically, pyrrolidine derivatives of formula (I) are useful in the treatment and/or prevention of neurodegenerative disorders, diseases associated with polygultamine tracts, epilepsy, ischemia, infertility, cardiovascular disorders renal hypoxia, hepatitis and AIDS. Said pyrrolidine derivatives display a modulatory and most notably a down-regulating-up to an inhibitory-activity with respect to the cellular death agonist Bax and/or the activation pathways leading to Bax and allows therefore to block the release of cytochrome (c). The present invention is furthermore related to novel pharmaceutically activity substituted pyrrolidine derivatives as well as to methods of their preparation, wherein X is selected from the group consisting of O, S, CR<6>R<7>, NOR<6>, NNR<6>R<7>; A is selected from the group consisting of -(C-O)-, -(C-O)-O-, -C(-NH)-, -(C-O)-NH-, -(C-S)-NH, -SO2-, -SO2NH-; -CH2-; B is either a group -(C-O)-NR<8>R<9> or represents a heterocyclic residue having the formula (II) wherein Q is NR<10>, O or S; n is an integer selected of 0, 1 or 2; Y, Z and E form together with the 2 carbons to which they are attached a 5-6 membered aryl or heteroaryl ring.
Patent AU-5233793-A (AU)
Title: Routing logic means
Inventor: PAUWELS BART JOSEPH GERARD
IPC: H04L12/56
Filed: 1993-12-06
Abstract: An asynchronous switching node is described for distributing cells from an input port (I1, . . . , IN) of a node (ND) to a group of output ports (LG1, . . . , Lgk) thereof. The asynchronous switching node includes switching stages (S1, S2, S3) each having a switching element (S11, . . . , S3N) with inlets (IP1-IPN) and outlets (OP1-OPN). Each switching element (S11, . . . , S3N) has a routing logic circuit (MC1; MC2; RL) for routing one of the cells from one of the inlets (IP1-IPN) of one of the switching element (S11, . . . , S3N) to one of the outlets (OP1-OPN) thereof based on an internal routing label (LGA; SRT) associated with a cell. The switching element (S11, . . . , S3N) uses the internal routing label (LGA; SRT) to identify at least one distribution tree having branches (BR1, . . . , BR6 ) which connect the input port (I1, . . . , IN) with the group of output ports (LG1, . . . , Lgk). The routing logic circuit (MC1; MC2; RL) has a preselection circuit (MB; M; RM) for preselecting under the control of the internal routing label (LGA; SRT) a set of the branches (BR1, . . . , BR6), has a selection circuit (MX; MX'; SEL) for dynamically selecting one of the branches (BR1, . . . , BR6) and has an identifier circuit for identifying a route on a selected outgoing branch (BR1, . . . , BR6) from the one switching element (S11, . . . , S3N).
Patent AU-5567994-A (AU)
Title: Multiple electrophoresis device and method for the migration and transfer of macromolecules
Inventor: COGNARD DOMINIQUE
IPC: B01D57/02
Filed: 1993-12-02
Abstract: Method and apparatus for multiple electrophoresis for the migration and transfer of macromolecules, in a tank (10) containing a plurality of parallel and elongate electrodes (14), membranes (22) arranged vertically in the tank between the columns of electrodes (14), and an electrophoresis gel which is introduced in liquid form into the tank and which is subsequently solidified in order to perform the electrophoresis. When the electrophoresis is finished, the gel is liquefied, dissolved or disintegrated, and the membranes (22) onto which the macromolecules have been transferred are removed from the tank. <IMAGE>
Patent AU-5733199-A (AU)
Title: Method for chromatographically purifying insulins
Inventor: SIEVERS WERNER
IPC: G01N30/26
Filed: 1999-08-11
Abstract: The present invention relates to an improved procedure for the chromatographic purification of insulins wherein a pressure-stable organic polymeric chromatography material is used as a stationary phase, and the mobile phase contains at least one water-miscible organic solvent and at least one buffer substance and the pH is from about 7 to about 11.
Patent AU-5783601-A (AU)
Title: Ink, ink-jet recording process, recorded article, recording unit, ink cartridge, ink-jet recording apparatus, fluorescence enhancing method and method of elongating life time of fluorescence
Inventor: NAGASHIMA AKIRA
IPC: C09D11/326
Filed: 2001-08-08
Abstract: Disclosed herein is an ink comprising 
(i) first and second organic compounds which are incompatible with each other; 
(ii) at least one of a compound exhibiting fluorescence properties and a coloring material exhibiting fluorescence properties; and 
(iii) a liquid medium dissolving or dispersing the components (i) and (ii) therein.
Patent AU-5959296-A (AU)
Title: Apparaus and method for treating cardiac arrhythmias with no discrete target
Inventor: BEN-HAIM SHLOMO
IPC: A61B5/296
Filed: 1996-05-31
Abstract: A method and apparatus for treating cardiac arrhythmias with no discrete focus. More particularly, one or more catheters are used to collect local information concerning a patient's heart, the information is analyzed to determine where lines or points of ablation should be made, and then the lines or points of ablation are made.
Patent AU-6306090-A (AU)
Title: Flame resistant to nonflammable composite panel
Inventor: SCHLATTER REINHARD
IPC: B29C67/24
Filed: 1990-09-21
Abstract: A fire-resistant or fireproof laminate (86) is produced from a non-extrudable core mixture (24) with a pourable, fireproof filling material and a binder, and covering bands adhesively bonded elastically to the core on both sides. 
<??>For a continuous production of the laminate (86) in one operation, the core mixture (24) is poured onto an elastic lower adhesive film (16), supported as it runs in, and a pile extending over the entire width is formed there. Between the elastic lower adhesive film and an elastic upper adhesive film (30), likewise supported as it runs in, material of the core mixture (24) is continuously and uniformly drawn through a wedge gap (40) and for the first time compressed and calibrated to thickness there. The adhesive films (16, 30) containing the precompressed core mixture (24) are bonded to the continuously fed-in covering bands. 
<??>The apparatus for carrying out the process comprises a spreader roll for each of the adhesive films (16, 30), a device for uniformly applying the core mixture (24), first means for forming an adjustable run-in angle ( beta ) and the wedge gap (40), second means for supporting the lower adhesive film (16) and third means for final pressing and heating, as well as a cutting-to-length device. 
<IMAGE>
Patent AU-6363199-A (AU)
Title: Treatment using oriented unidirectional dc magnetic field
IPC: A61N2/04
Filed: 1999-07-12
Abstract: A method of treating a patient who lives in a relatively weak magnetic field such as is naturally present by using an oriented, unidirectional, DC magnetic field. The magnetic field is aligned to pass through the patient's body in substantially the same direction that the Earth's magnetic field did during the majority of recent cell division within the patient's body. The first step of the present invention is to determine what the orientation of the Earth's magnetic field has been with respect to the patient's body during cell division in the recent past. The next step is to position the patient's body within a treating magnetic field. The magnetic field is oriented to correspond to some extent to the direction of the Earth's magnetic field determined in the first step. The magnetic field is constrained to prevent fringing magnetic fields from passing through any part of the patient's body in an obtuse direction with respect to the direction of the Earth's magnetic field determined in the first step. The treating magnetic field has zero frequency and is at least 500 gauss in intensity at its weakest point within the portion of the patient's body to be treated.
Patent AU-6580786-A (AU)
Title: Method and apparatus for transmitting video data
Inventor: KONDO TETSUJIRO
IPC: H04N7/46
Filed: 1986-11-28
Abstract: Disclosed is an apparatus for transmitting video signals comprising an input device for receiving video data of sequential fields a memory for storing the video data of a plurality of fields, parameter generating devices for generating respective parameters to specify a time spatial relation which is defined by a linear combination from reference pixel data of a plurality of fields to be periodically transmitted every predetermined number of fields and pixel data of a respective field to be skipped between the plurality of fields to be periodically transmitted each being stored in memory. Means are provided for transmitting the video data of the fields to be periodically transmitted every predetermined number of fields and the respective parameters instead of the video data of the respective field to be skipped.
Patent AU-6795190-A (AU)
Title: Diaphragm control valve
Inventor: WEINGARTEN ZVI
IPC: F16K7/17
Filed: 1990-12-11
Abstract: The diaphragm control valve includes a diaphragm valve member (12) having an outer peripheral section (14a) for securing the diaphragm (14) within the valve housing (2), a valve-closer section (145) displaceable with respect to the valve seat (10) for controlling the flow, an intermediate flexible section (14c) permitting the displacement of the valve-closer section (14b), and a cylindrical guiding section (14d) between the valve-closer section (14b) and the intermediate flexible section (14c). The housing (2) includes a cylindrical guiding surface (24) engageable with the cylindrical guiding section (14d) of the diaphragm (14) and with the valve-closer section (14b) for guiding the movement of the valve-closer section (14b). <IMAGE>
Patent AU-6855596-A (AU)
Title: Multi-subtype fiv vaccines
Inventor: YAMAMOTO JANET K
IPC: C12N5/0783
Filed: 1996-08-23
Abstract: The subject invention pertains to novel methods and compositions for protecting cats from infection by a broad range of FIV strains using a multi-subtype FIV vaccine. Multi-subtype FIV vaccines comprising either cell free whole virus or cell lines infected with viruses are described. Methods for vaccinating cats with the subject vaccine compositions are also described. Cats vaccinated according to the methods and compositions of the subject invention exhibit protective humoral and cellular immune responses to FIV when challenged with homologous or heterologous strains of FIV. The subject invention also pertains to novel feline cell lines that are susceptible to infection by FIV and their methods of use.
Patent AU-7057096-A (AU)
Title: Kiln
Inventor: GRUNENFELDER ROBERT
IPC: F27B17/02
Filed: 1996-11-04
Abstract: A kiln has a bottom part with a support for goods to be fired and a top part with a firing chamber. A bearing arrangement including at least one pivot joint pivotably connects the bottom part and the top part. The bearing arrangement includes a lift bearing cooperating with the at least one pivot joint.
Patent AU-7488894-A (AU)
Title: Method and device for minimizing the energy consumption of an electrical load
Inventor: BALDENWEG URS
IPC: G04G15/00
Filed: 1994-09-02
Abstract: PCT No. PCT/CH94/00172 Sec. 371 Date Apr. 7, 1995 Sec. 102(e) Date Apr. 7, 1995 PCT Filed Sep. 2, 1994 PCT Pub. No. WO95/07500 PCT Pub. Date Mar. 16, 1995A controlling device is operated continuously throughout the day to minimize the energy consumption of an electrical load. The controlling device processes at least one primary measured value and at least one primary nominal value to obtain a control value. The control value is output by the controlling device for controlling the flow of energy to the electrical load throughout the day. The at least one primary nominal value is adjusted for individual conditions occurring throughout the day by using an output obtained by processing at least one secondary measured value and at least one secondary nominal value. The at least one secondary measured value is influenced by a user. The energy consumption of the electrical load is minimized while the comfort level of the electrical load (i.e., readiness of the electrical load when usage is expected) is maximized or optimized.
Patent AU-7495487-A (AU)
Title: Oxygen barrier film
Inventor: SHAH GAUTAM P
IPC: B65D65/40
Filed: 1987-06-30
Abstract: A coextruded multiple layer oriented film comprises a core layer comprising an ethylene vinyl alcohol copolymer, two intermediate adhesive layers, and two outer layers comprising a polymeric material selected from the group consisting of ethylene butyl acrylate copolymer, and blends comprising at least 10% of said ethylene butyl acrylate copolymer blended with ethylene alpha-olefin copolymers. A preferred embodiment of the multilayer film exhibits high oxygen barrier especially useful in food packaging applications.
Patent AU-7625387-A (AU)
Title: A process for preparing cimetidine polymorph B.
Inventor: GRABOYES HAROLD
IPC: C07D233/64
Filed: 1987-07-29
Abstract: A novel process for preparing cimetidine polymorph "B" comprises precipitating cimetidine from an aqueous-alcoholic solution of an acid addition salt. The precipitation is conducted at a temperature of above 15 DEG C.
Patent AU-7881194-A (AU)
Title: Coccidiosis poultry vaccine
Inventor: BUMSTEAD JANENE MARILYN
IPC: C07K16/00
Filed: 1994-11-14
Abstract: This invention relates to novel Eimeria proteins with immunogenic properties as well as to DNA sequences encoding these proteins. These proteins can be administered to poultry thereby protecting the birds against coccidiosis. In addition the DNA encoding these proteins can be used for the preparation of a vector vaccine against coccidiosis.